1)Krieger JN, Nyberg L Jr and Nickel JC:NIH consensus definition and classification of Prostatitis. JAMA 282:236-237, 1999
2)Wagenlehner FM, Schneider H, Ludwig M, et al:A pollen extract(Cernilton)in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome:a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 56:544-551, 2009
3)Mehik A, Alas P, Nickel JC, et al:Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome:a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 62:425-429, 2003
4)柿崎秀宏,吉田正貴(編集):ファーマナビゲーター 下部尿路機能障害編 第1版.メディカルレビュー社,大阪,2008
5)Basbaum AI and Fields HL:The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat:further studies on the anatomy of pain modulation. J Comp Neurol 187:513-531, 1979
6)Suzuki T, Li YH and Mashimo T:The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation. Anesthesia & Analgesia 101:793-799, 2005
7)Kawamura M, Ohara H, Go K, et al:Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving5-HT3 and noradrenergic α2 receptors in spinal dorsal horn. Life Sciences 62:2181-2190, 1998
8)日本泌尿器科学会尿路感染症臨床試験ガイドライン作成委員会編:尿路感染症臨床試験ガイドライン 第一版,金原出版,東京,1998
9)門田晃一,津川昌也,二ノ宮祐子,他:The National Institutes of Health chronic prostatitis symptom index(NIH-CPSI,日本語版・岡山大学案)の有用性と同案を用いた慢性非細菌性前立腺炎に対するセルニチンポーレンエキスの臨床評価,日本泌尿器科学会雑誌 93:539-547,2002
10)横田敏勝:臨床医のための痛みのメカニズム 改訂第2版,南江堂,東京,1997
11)Elena EU, Matthew OF and Michael AP:Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn 29:77-81, 2010
12)Shibayama Y, Reddigari SR, Teruya M, et al:Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor. Biochem Pharmacol 55:1175-1180, 1998